Absorbed dose distributions in patients with bone metastases from hormone refractory prostate cancer treated with Re-186 HEDP

被引：0
|
作者：
Bacelar, A. M. Denis [1 ]
Divoli, A. [2 ]
Chittenden, S. [2 ]
Du, Y. [2 ]
Dearnaley, D. P. [1 ]
O'Sullivan, J. M. [3 ]
Flux, G. D. [2 ]
机构：
[1] Inst Canc Res, Sutton, Surrey, England
[2] Royal Marsden Hosp, Sutton, Surrey, England
[3] Queens Univ Belfast, Belfast City Hosp, Belfast, Antrim, North Ireland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [41] Re: Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases
    Schmid, Hans-Peter
    Theiler, Robert
    EUROPEAN UROLOGY, 2012, 61 (02) : 427 - 428
  • [42] Radionuclide treatment for painful bone metastases in patients with hormone-refractory prostate cancer
    Dolezal, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S350 - S350
  • [43] Quantitative analysis of bone scans to determine if the dose to individual metastases from high activity Re186HEDP therapy depends upon the number of metastases
    McCready, VR
    O'Sullivan, J
    Dearnaley, D
    Treleaven, J
    RADIOLOGY, 2001, 221 : 344 - 344
  • [44] Efficacy and Side Effects of 186Re-HEDP in Bone Pain Palliation of Patients with Widespread Skeletal Metastases
    Pirayesh, E.
    Amoui, M.
    Mirzaie, H.
    Asli, I. Neshandar
    Tabei, F.
    Rakhsha, A.
    Shafie, B.
    Gandomkar, M.
    Kalantari, B.
    Panah, B. Davar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S304 - S305
  • [45] Metastatic bone pain palliation with 89‐Sr and 186‐Re‐HEDP in breast cancer patients
    Rosa Sciuto
    Anna Festa
    Rosella Pasqualoni
    Alessandro Semprebene
    Sandra Rea
    Serenella Bergomi
    Carlo L. Maini
    Breast Cancer Research and Treatment, 2001, 66 : 101 - 109
  • [46] Evaluation of absorbed does of 188Re-HEDP in patients with bone metastases using gamma camera.
    Lee, JS
    Choi, CW
    Kim, BI
    Yang, WI
    Lim, SM
    Hong, SW
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 239P - 239P
  • [47] Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy
    Denis-Bacelar, Ana M.
    Chittenden, Sarah J.
    McCready, V. Ralph
    Divoli, Antigoni
    Dearnaley, David P.
    O'Sullivan, Joe M.
    Johnson, Bernadette
    Flux, Glenn D.
    BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1084):
  • [48] Palliative treatment of painful disseminated bone metastases with 186rhenium-HEDP in patients with lung cancer
    Leondi, AH
    Souvatzoglou, MA
    Rapti, AS
    Leontopoulou, SA
    Paadaki, EK
    Datseris, IE
    Anagnostopoulou, US
    Zerva, CJ
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 48 (03): : 211 - 219
  • [49] PBSC Transplantation in patients receiving ablative doses of 186Re HEDP for skeletal secondaries from prostate cancer
    McCready, R
    Treleaven, J
    Al Deen, A
    Dearnaley, D
    Powles, R
    BONE MARROW TRANSPLANTATION, 1998, 21 : S227 - S227
  • [50] Retrospective dosimetry in palliative molecular radiotherapy with 186Re-HEDP for bone pain in patients with castrate-resistant prostate cancer
    Denis-Bacelar, A. M.
    Divoli, A.
    Chittenden, S.
    Du, Y.
    Dearnaley, D. P.
    O'Sullivan, J. M.
    Frisch, K. J.
    Flux, G. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S174 - S175
12345